Detailed price information for Nasdaq Biotechnology Ishares ETF (IBB-Q) from The Globe and Mail including charting and trades.

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

The field of biotechnology has always transformed cutting-edge science into life-changing medicines, but today that transformation is happening at a staggering pace.

BIOTECanada welcomes the federal budget’s focus on advancing Canada’s life sciences sector through investment and regulatory ...

Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...

Detailed price information for Nasdaq Biotechnology Ishares ETF (IBB-Q) from The Globe and Mail including charting and trades ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

Biotechnology and biomedical engineering are distinct yet impactful fields shaping healthcare's future. Biotechnology delves into biological systems for drug development and genetic breakthroughs, ...

ValGenesis has a two-decade history of innovation in life sciences technology. In 2005, the company introduced the world's first digital validation lifecycle management system-a breakthrough that ...

Analysts expect PDS Biotechnology to report an earnings per share (EPS) of $-0.20. PDS Biotechnology bulls will hope to hear ...